Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 4
2004 6
2005 4
2006 9
2007 5
2008 7
2009 8
2010 7
2011 4
2012 4
2013 6
2014 7
2016 5
2017 7
2018 8
2019 12
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32723804

102 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial.
Akizawa T, Nangaku M, Yonekawa T, Okuda N, Kawamatsu S, Onoue T, Endo Y, Hara K, Cobitz AR. Akizawa T, et al. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1155-1165. doi: 10.2215/CJN.16011219. Epub 2020 Jul 28. Clin J Am Soc Nephrol. 2020. PMID: 32723804
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.
Akizawa T, Iwasaki M, Yamaguchi Y, Majikawa Y, Reusch M. Akizawa T, et al. J Am Soc Nephrol. 2020 Jul;31(7):1628-1639. doi: 10.1681/ASN.2019060623. Epub 2020 Jun 3. J Am Soc Nephrol. 2020. PMID: 32493693
A 24-Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients.
Tsubakihara Y, Akizawa T, Nangaku M, Onoue T, Yonekawa T, Matsushita H, Endo Y, Cobitz A. Tsubakihara Y, et al. Ther Apher Dial. 2020 Apr;24(2):108-114. doi: 10.1111/1744-9987.12962. Epub 2019 Aug 13. Ther Apher Dial. 2020. PMID: 31306555
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
Holdstock L, Cizman B, Meadowcroft AM, Biswas N, Johnson BM, Jones D, Kim SG, Zeig S, Lepore JJ, Cobitz AR. Holdstock L, et al. Clin Kidney J. 2019 Feb;12(1):129-138. doi: 10.1093/ckj/sfy013. Epub 2018 Mar 9. Clin Kidney J. 2019. PMID: 30746140 Free PMC article.
Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ. Nissenson AR, et al. Am J Kidney Dis. 2002 Jul;40(1):110-8. doi: 10.1053/ajkd.2002.33919. Am J Kidney Dis. 2002. PMID: 12087568 Clinical Trial.
Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects.
Akizawa T, Tsubakihara Y, Nangaku M, Endo Y, Nakajima H, Kohno T, Imai Y, Kawase N, Hara K, Lepore J, Cobitz A. Akizawa T, et al. Am J Nephrol. 2017;45(2):127-135. doi: 10.1159/000454818. Epub 2016 Dec 16. Am J Nephrol. 2017. PMID: 27978511 Clinical Trial.
Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial.
Schwartzberg L, Burkes R, Mirtsching B, Rearden T, Silberstein P, Yee L, Inamoto A, Lillie T. Schwartzberg L, et al. BMC Cancer. 2010 Oct 25;10:581. doi: 10.1186/1471-2407-10-581. BMC Cancer. 2010. PMID: 20973982 Free PMC article. Clinical Trial.
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.
Bailey CK, Caltabiano S, Cobitz AR, Huang C, Mahar KM, Patel VV. Bailey CK, et al. BMC Nephrol. 2019 Oct 16;20(1):372. doi: 10.1186/s12882-019-1547-z. BMC Nephrol. 2019. PMID: 31619187 Free PMC article.
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
Meadowcroft AM, Cizman B, Holdstock L, Biswas N, Johnson BM, Jones D, Nossuli AK, Lepore JJ, Aarup M, Cobitz AR. Meadowcroft AM, et al. Clin Kidney J. 2019 Feb;12(1):139-148. doi: 10.1093/ckj/sfy014. Epub 2018 Mar 19. Clin Kidney J. 2019. PMID: 30746141 Free PMC article.
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.
Vansteenkiste J, Hedenus M, Gascon P, Bokemeyer C, Ludwig H, Vermorken J, Hamilton L, Bridges K, Pujol B. Vansteenkiste J, et al. BMC Cancer. 2009 Sep 3;9:311. doi: 10.1186/1471-2407-9-311. BMC Cancer. 2009. PMID: 19728887 Free PMC article. Clinical Trial.
102 results
Jump to page
Feedback